Literature DB >> 18179506

Comorbid conditions and glycemic control in elderly patients with type 2 diabetes mellitus, 1988 to 1994 to 1999 to 2004.

Dong-Churl Suh1, Chul-Min Kim, In-Sun Choi, Craig A Plauschinat.   

Abstract

OBJECTIVES: To compare the prevalence of type 2 diabetes mellitus in the U.S. elderly population between 1988 to 1994 and 1999 to 2004 and to assess glycemic control and comorbid conditions in this population.
DESIGN: Serial U.S. population-based cross-sectional surveys.
SETTING: National Health and Nutrition Examination Surveys (1988-1994 and 1999-2004). PARTICIPANTS: Survey participants aged 65 and older with type 2 diabetes mellitus. MEASUREMENTS: Glycemic control, measured as hemoglobin A1C (hA1C) less than 7%, prevalence of comorbid conditions, pharmacologic treatment rate, blood pressure, and serum cholesterol.
RESULTS: The prevalence of diagnosed type 2 diabetes mellitus in the U.S. elderly population increased from 12.0% to 14.1% (P=.004) between 1988 and 2004. Many patients had comorbid conditions; in 1999 to 2004, 36.7% had nephropathy, 31.5% renal insufficiency, 20.2% history of myocardial infarction, and 17.9% heart failure. The proportion of patients treated with antihyperglycemic medication increased from 75.1% in 1988 to 1994 to 85.6% in 1999 to 2004 (P<.001), and glycemic control rates also improved, from 44.7% to 54.8% (P<.001). Greater improvement in glycemic control rates was evident in patients without comorbidities (P<.001). Adjusted for patient characteristics, including duration of diabetes mellitus, patients with nephropathy or renal insufficiency were 40% less likely to achieve controlled hA1C as those without.
CONCLUSION: Despite improvements in the rates of treatment and glycemic control, approximately half of elderly patients diagnosed with type 2 diabetes mellitus have hA1C levels of 7% or higher. Many patients suffer from comorbid conditions, which may present a challenge for successful diabetes mellitus management.

Entities:  

Mesh:

Year:  2008        PMID: 18179506     DOI: 10.1111/j.1532-5415.2007.01563.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  20 in total

1.  Association of A1C levels with vitamin D status in U.S. adults: data from the National Health and Nutrition Examination Survey.

Authors:  Jatupol Kositsawat; Vincent L Freeman; Ben S Gerber; Stephen Geraci
Journal:  Diabetes Care       Date:  2010-03-09       Impact factor: 19.112

2.  Choosing targets for glycaemia, blood pressure and low-density lipoprotein cholesterol in elderly individuals with diabetes mellitus.

Authors:  Susan R Kirsh; David C Aron
Journal:  Drugs Aging       Date:  2011-12-01       Impact factor: 3.923

Review 3.  The association between diabetes and depression: a very disabling condition.

Authors:  Vincenzo Fiore; Massimo Marci; Antonella Poggi; Vito Angelo Giagulli; Brunella Licchelli; Massimo Iacoviello; Edoardo Guastamacchia; Giovanni De Pergola; Vincenzo Triggiani
Journal:  Endocrine       Date:  2014-06-14       Impact factor: 3.633

4.  Influence of chronic comorbidity and medication on the efficacy of treatment in patients with diabetes in general practice.

Authors:  Welcome Mkululi Wami; Frank Buntinx; Stefaan Bartholomeeusen; Geert Goderis; Chantal Mathieu; Marc Aerts
Journal:  Br J Gen Pract       Date:  2013-04       Impact factor: 5.386

5.  Factors associated with poor glycemic control in older Mexican American diabetics aged 75 years and older.

Authors:  Max E Otiniano; Soham Al Snih; James S Goodwin; Laura Ray; Majd AlGhatrif; Kyriakos S Markides
Journal:  J Diabetes Complications       Date:  2012-04-18       Impact factor: 2.852

6.  Clinical complexity and mortality in middle-aged and older adults with diabetes.

Authors:  Christine T Cigolle; Mohammed U Kabeto; Pearl G Lee; Caroline S Blaum
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-04-06       Impact factor: 6.053

7.  Efficacy and safety of insulin glargine compared to other interventions in younger and older adults: a pooled analysis of nine open-label, randomized controlled trials in patients with type 2 diabetes.

Authors:  Naushira Pandya; Andres DiGenio; Ling Gao; Meenakshi Patel
Journal:  Drugs Aging       Date:  2013-06       Impact factor: 3.923

8.  Does Device Make Any Difference? A Real-world Retrospective Study of Insulin Treatment Among Elderly Patients With Type 2 Diabetes.

Authors:  Raymond Miao; Wenhui Wei; Jay Lin; Lin Xie; Onur Baser
Journal:  J Diabetes Sci Technol       Date:  2014-01-01

9.  Comorbidity and glycemia control among patients with type 2 diabetes in primary care.

Authors:  Catherine Hudon; Martin Fortin; Marie-France Dubois; José Almirall
Journal:  Diabetes Metab Syndr Obes       Date:  2008-11-18       Impact factor: 3.168

10.  Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus and comparison of hypoglycemic action of concomitant medications: a subanalysis of the JAMP study.

Authors:  Noriko Ujihara; Hiroshi Sakura; Naotake Hashimoto; Kazuo Sasamoto; Hiroshi Ohashi; Sumiko Hasumi; Tadasu Kasahara; Osamu Tomonaga; Hideo Nunome; Masashi Honda; Yasuhiko Iwamoto
Journal:  Diabetol Int       Date:  2017-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.